Elicio Therapeutics, Inc.
ELTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601485
No open-market purchases or sales by Elicio Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $15.3M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Elicio Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +9 vs. Q3 2025
- Shares held
- 2.08M
- +168.5K (+8.8%) vs. Q3 2025
- Total value
- $16.6M
- −$4.32M (−20.7%) vs. Q3 2025
- New holders
- 13
- 10 more added
- Sold out
- 4
- 5 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $15.3M |
| Q1 2026 | 47 | $28.2M |
| Q4 2025 | 37 | $16.6M |
| Q3 2025 | 28 | $20.9M |
| Q2 2025 | 21 | $11.2M |
| Q1 2025 | 24 | $9.80M |
| Q4 2024 | 17 | $2.25M |
| Q3 2024 | 18 | $2.48M |
| Q2 2024 | 20 | $2.68M |
| Q1 2024 | 18 | $3.08M |
| Q4 2023 | 18 | $2.78M |
| Q3 2023 | 18 | $2.80M |
| Q2 2023 | 15 | $2.71M |
| Q1 2023 | 28 | $2.56M |
| Q4 2022 | 30 | $3.98M |
| Q3 2022 | 38 | $4.71M |
| Q2 2022 | 43 | $5.90M |
| Q1 2022 | 47 | $13.8M |
| Q4 2021 | 53 | $20.3M |
| Q3 2021 | 47 | $69.3M |
| Q2 2021 | 41 | $66.5M |
| Q1 2021 | 41 | $92.0M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Elicio Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Knoll Capital Management, LLC | 630,915 | $5.02M | 2.30% | 00.0% | Unchanged |
| Vanguard Group Inc | 496,901 | $3.96M | 0.00% | +23,042+4.9% | Added |
| Balyasny Asset Management LLC | 138,762 | $1.10M | 0.00% | −9,314−6.3% | Reduced |
| Geode Capital Management, LLC | 132,518 | $1.06M | 0.00% | +2,832+2.2% | Added |
| Marshall Wace, LLP | 117,200 | $932.9K | 0.00% | +30,667+35.4% | Added |
| Susquehanna International Group, LLP | 64,052 | $509.9K | 0.00% | −56,155−46.7% | Reduced |
| 683 Capital Management, LLC | 56,442 | $449.3K | 0.04% | +56,442 | New |
| Northern Trust Corp | 52,769 | $420.0K | 0.00% | −815−1.5% | Reduced |
| State Street Corp | 46,300 | $368.5K | 0.00% | +8,000+20.9% | Added |
| BlackRock, Inc. | 45,179 | $359.6K | 0.00% | +984+2.2% | Added |
| UBS Group AG | 32,016 | $254.8K | 0.00% | +24,997+356.1% | Added |
| Renaissance Technologies LLC | 28,111 | $223.8K | 0.00% | −20,560−42.2% | Reduced |
| CM Management, LLC | 25,000 | $199.0K | 0.17% | +19,000+316.7% | Added |
| Omers Administration Corp | 23,500 | $187.1K | 0.00% | +23,500 | New |
| Qube Research & Technologies Ltd | 20,216 | $160.9K | 0.00% | +20,216 | New |
| Quadrature Capital Ltd | 17,159 | $136.6K | 0.00% | +17,159 | New |
| Squarepoint Ops LLC | 16,662 | $132.6K | 0.00% | +16,662 | New |
| Occudo Quantitative Strategies LP | 15,827 | $126.0K | 0.01% | +15,827 | New |
| Morgan Stanley | 14,553 | $115.8K | 0.00% | +13,017+847.5% | Added |
| Meyer Handelman Co | 13,899 | $110.6K | 0.00% | 00.0% | Unchanged |
| Jefferies Financial Group Inc. | 11,942 | $95.1K | 0.00% | +6,742+129.7% | Added |
| Point72 Asset Management, L.P. | 11,652 | $92.8K | 0.00% | +11,652 | New |
| HighTower Advisors, LLC | 11,186 | $89.0K | 0.00% | +11,186 | New |
| Summit Financial, LLC | 10,010 | $79.7K | 0.00% | +10,010 | New |
| Wiley Bros.-Aintree Capital, LLC | 10,000 | $79.6K | 0.00% | 00.0% | Unchanged |
| Moody Lynn & Lieberson, LLC | 10,000 | $79.6K | 0.00% | 00.0% | Unchanged |
| Mayflower Financial Advisors, LLC | 10,000 | $79.6K | 0.01% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 7,000 | $55.7K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 5,668 | $45.1K | 0.00% | +5,668 | New |
| Steward Partners Investment Advisory, LLC | 1,554 | $12.4K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,157 | $9.21K | 0.00% | −2,428−67.7% | Reduced |
| Farther Finance Advisors, LLC | 705 | $5.61K | 0.00% | +65+10.2% | Added |
| Group One Trading, L.P. | 323 | $2.57K | 0.00% | +323 | New |
| Royal Bank of Canada | 219 | $2.00K | 0.00% | +219 | New |
| Wells Fargo & Company | 200 | $1.59K | 0.00% | 00.0% | Unchanged |
| Fortitude Family Office, LLC | 93 | $740 | 0.00% | +93 | New |
| SBI Securities Co., Ltd. | 82 | $653 | 0.00% | 00.0% | Unchanged |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −26,925−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −22,846−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −10,658−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −103−100.0% | Sold out |